Compare ARK Genomic Revolution ETF (ARKG) vs Ross Stores, Inc. (ROST) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Ross Stores, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Ross Stores, Inc. trades at $222 (market cap $71.50B). The key difference: Ross Stores, Inc. pays a 0.8% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | ROST | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $240.13 |
52-Week Low | $23.09 | $127.59 |
Market Cap | — | $71.50B |
Enterprise Value | — | $72.09B |
Dividend Yield | — | 0.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Ross Stores (ROST) trades at $222.88, up 1.02% with strong momentum near recent highs. The stock shows bullish technical signals with consistent earnings beats in recent quarters (Q3 2025-Q1 2026) and robust fundamentals including 38.98% ROE and 9.74% net margin. Revenue growth accelerated to $21.13B in 2025, with analyst consensus strongly favoring Buy ratings (63.83%) and a $259 price target representing 16% upside potential.
Outlook remains positive given strong operational execution and consumer demand, though valuation multiples (P/E 31.13) appear elevated. Key risks include retail sector competition and economic sensitivity. Institutional sentiment supports further gains if earnings momentum continues through Q2 2026 results.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →
